Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCitius Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.38 | -$1.38 | -$1.38 |
| Q2 2024 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q3 2024 | 1 | -$1.53 | -$1.53 | -$1.53 |
| Q4 2024 | 1 | -$1.37 | -$1.37 | -$1.37 |
| Q1 2025 | 1 | -$0.95 | -$0.95 | -$0.95 |
| Q2 2025 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q3 2025 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q4 2025 | 1 | $4.50 | $4.50 | $4.50 |
| Q1 2026 | 1 | $4.50 | $4.50 | $4.50 |
| Q2 2026 | 1 | $4.75 | $4.75 | $4.75 |
| Q3 2026 | 1 | $5.25 | $5.25 | $5.25 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
Citius Pharmaceuticals, Inc. Earnings Date And Information
Citius Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 27th, 2024. The company reported $-1.5 earnings per share for the quarter, missing analysts' consensus estimates of $-0.04 by $1.46. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Citius Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.22 diluted earnings per share) and currently has a price-to-earnings ratio of -11.8. Citius Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 27th, 2024 based on prior year's report dates.
Citius Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q3 2024 | -$1.25 | -$0.06 | 1.19 | $15.43 M | $0 |
| 05/14/2024 | Q2 2024 | -$1.50 | -$0.05 | 1.45 | $0 | |
| 02/14/2024 | Q1 2024 | $3.25 | -$0.06 | -3.31 | $0 | |
| 12/29/2023 | Q4 2023 | -$0.44 | -$0.06 | 0.37 | $0 | |
| 08/14/2023 | Q3 2023 | -$1.50 | -$0.06 | 1.44 | $0 | |
| 05/12/2023 | Q2 2023 | -$1.00 | -$0.07 | 0.93 | $0 | |
| 02/10/2023 | Q1 2023 | -$0.02 | $0 | |||
| 12/22/2022 | Q4 2022 | -$1.00 | -$0.05 | 0.95 | $0 | |
| 08/11/2022 | Q3 2022 | -$1.25 | -$0.06 | 1.19 | $0 | |
| 05/12/2022 | Q2 2022 | -$2.00 | -$0.05 | 1.95 | $0 | |
| 02/10/2022 | Q1 2022 | -$1.50 | -$0.06 | 1.44 | $0 | |
| 12/15/2021 | Q4 2021 | -$0.75 | -$0.03 | 0.72 | $0 | |
| 08/12/2021 | Q3 2021 | -$0.04 | $0 | |||
| 05/13/2021 | Q2 2021 | -$0.04 | $0 | |||
| 02/11/2021 | Q1 2021 | -$0.15 | $0 | |||
| 12/16/2020 | Q4 2020 | -$0.11 | $0 | |||
| 08/14/2020 | Q3 2020 | -$0.11 | $0 | |||
| 05/14/2020 | Q2 2020 | -$0.13 | $0 | |||
| 02/13/2020 | Q1 2020 | -$0.15 | $0 | |||
| 12/16/2019 | Q4 2019 | -$0.18 | $0 |
Citius Pharmaceuticals, Inc. Earnings: FAQ's
When is Citius Pharmaceuticals, Inc.'s earnings date?
Citius Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 27th, 2024 based off last year's report dates.
How can I listen to Citius Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Citius Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Citius Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Citius Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does Citius Pharmaceuticals, Inc. generate each year?
Citius Pharmaceuticals, Inc. (:CTXR) has a recorded net income of $0. Citius Pharmaceuticals, Inc. has generated $-0.23 earnings per share over the last four quarters.
What is Citius Pharmaceuticals, Inc.'s price-to-earnings ratio?
Citius Pharmaceuticals, Inc. (:CTXR) has a price-to-earnings ratio of -11.8 and price/earnings-to-growth ratio is 2.72.